Subscribe
type here...
Subscribe

Tag: clinical studies

Australian Biotron’s share price rose 38% due to COVID-19 study results

Global Markets Techno -
Shares in the small-cap biotech jumped 37.5% to 9.9 cents each after reporting positive COVID-19 animal trial results today. Biotron...

Nkarta presented the first finished NK cell data showing multiple complete responses with full hematologic recovery

Drug Development Techno -
Nkarta, Inc., a biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, announced positive preliminary Phase 1...

FDA partially suspends study of Curis’ lymphoma drug

Regulatory Techno -
Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, April 11th...

Combination of biomarkers discovered that can to identify subcortical small-vessel disease

Expert Opinion Techno -
In recent years, subcortical small-vessel disease has become an increasingly common cognitive diagnosis. Researchers at University of Gothenburg have...

Deliberate COVID-19 infection trial finds symptoms don’t indicate viral shedding

Global Markets Techno -
The world's first "human challenge" trial in which volunteers were deliberately exposed to the coronavirus has found that symptoms...

Tonix’s leading fibromyalgia drug failed again in a study, bringing the stock even closer to zero

Global Markets Techno -
Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced on Monday that, TNX-102 SL (cyclobenzaprine HCl sublingual tablets)...

The world’s fastest supercomputer and AI technology for scientific discovery

Global Markets Techno -
Fujitsu and the Tokyo Medical and Dental University (TMDU) today announced a new technology that uses AI to discover...

Gustave Roussy and Anju Software to Accelerate Complex Oncology Clinical Studies

Global Markets Techno -
Anju Software announced that Gustave Roussy, one of the top five cancer research centers in the world and Europe's top-ranked...

The combination of AstraZeneca and Sputnik Light vaccines in Azerbaijan shows strong neutralizing antibodies growth

Global Markets Techno -
R-Pharm Group, the Russian Direct Investment Fund (RDIF) and AstraZeneca announce preliminary virus neutralizing activity results of combined use...

Combination of the Sputnik Light with others vaccines demonstrates high safety profile

Drug Development Techno -
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik V – the world’s first registered vaccine against coronavirus.

BIOCAD has presented the results of efficacy evaluation of the Russian immuno-oncology product prolgolimab for the treatment of melanoma

Manufacturing Techno -
In the evening of June 21, 2021, leading Russian and international cancer experts presented the results of a three-year...

Sanofi and GSK initiate global Phase 3 clinical efficacy study of COVID-19 vaccine candidate

Drug Development Techno -
Sanofi and GSK started enrollment in their Phase 3 clinical study to assess the safety, efficacy, and immunogenicity of...

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

Headlines

Newsletter

Get important news delivered directly to your inbox and stay connected!

© PHARMPROM 2026